You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AURX Award Disclosure
Jorden David Emerson · SEC Form 4 · Filed Aug 28, 2026
Award
Calculated transaction value
$8.69K
Jorden David Emerson CEO/CFO
AURX
Transaction date
Aug 28, 2026
Public filing date
Aug 28, 2026
Filing lag
Filed same day
AURX daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 7,984 shares @ $1.09
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001437749-26-029236
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$9.54K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Nuo Therapeutics, Inc. AURX Current | Award | Aug 28, 2026 | $8.69K |
| Nuo Therapeutics, Inc. AURX | Award | Aug 27, 2026 | $844.23 |